Last 12 months
Inside the activity.
0 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 35 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2019 Filed Nov 13, 2019 21:11 UTC |
BROWN MICHAEL SDirector
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-19-000012 · edgardoc.xml · nonDerivative · entry 3 BROWN MICHAEL S · CIK 0001174475 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,349 Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 21:11 UTC |
BROWN MICHAEL SDirector
|
SaleCommon Stock | 4,500 | $349.00 | $1,570,500.00 |
DisclosureSEC source: 0001708138-19-000012 · edgardoc.xml · nonDerivative · entry 2 BROWN MICHAEL S · CIK 0001174475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 21:11 UTC |
BROWN MICHAEL SDirector
|
Exercise / conversionCommon Stock | 4,500 | $273.67 | $1,231,515.00 |
DisclosureSEC source: 0001708138-19-000012 · edgardoc.xml · nonDerivative · entry 1 BROWN MICHAEL S · CIK 0001174475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 22:02 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 1,000 | $340.44 | $340,440.00 |
DisclosureSEC source: 0001237899-19-000018 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,323 F1 · price: Represents volume-weighted average price of sales of 1,000 shares of Company stock on November 8, 2019 at prices ranging from $340.43 to $340.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 300 | $341.38 | $102,414.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 11 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,455 F9 · price: Represents volume-weighted average price of sales of 300 shares of Company stock on November 8, 2019 at prices ranging from $341.09 to $341.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 2,064 | $340.48 | $702,750.72 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 10 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,755 F8 · price: Represents volume-weighted average price of sales of 2,064 shares of Company stock on November 8, 2019 at prices ranging from $340.00 to $340.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 1,100 | $339.53 | $373,483.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 9 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,819 F7 · price: Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 8, 2019 at prices ranging from $339.05 to $339.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 1,100 | $338.54 | $372,394.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 8 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,919 F6 · price: Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 8, 2019 at prices ranging from $338.10 to $338.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 1,500 | $337.41 | $506,115.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 7 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,019 F5 · price: Represents volume-weighted average price of sales of 1,500 shares of Company stock on November 8, 2019 at prices ranging from $337.03 to $337.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 500 | $336.73 | $168,365.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 6 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,519 F4 · price: Represents volume-weighted average price of sales of 500 shares of Company stock on November 8, 2019 at prices ranging from $336.48 to $336.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 400 | $335.45 | $134,180.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 5 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,019 F3 · price: Represents volume-weighted average price of sales of 400 shares of Company stock on November 8, 2019 at prices ranging from $335.02 to $335.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 100 | $334.66 | $33,466.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 4 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,419 F2 · price: Represents volume-weighted average price of sales of 100 shares of Company stock on November 8, 2019 at prices ranging from $334.48 to $334.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 200 | $333.32 | $66,664.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 3 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,519 F1 · price: Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2019 at prices ranging from $333.31 to $333.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 100 | $330.56 | $33,056.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 2 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,719 Read SEC document |
| October 02, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 764 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 17 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · by CLAT Disclosed balance after: 144,897 Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 21:00 UTC |
Sanofi10% owner
|
SaleCommon Stock | 172,904 | $281.15 | $48,611,803.99 |
DisclosureSEC source: 0001140361-19-016600 · form4.xml · nonDerivative · entry 1 Sanofi · CIK 0001121404 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,550,813 F1 · kind: Private sale to the Issuer pursuant to the letter agreement entered into with the Issuer on January 7, 2018 and filed on January 9, 2018 by the Reporting Person as Exhibit 99.4 to Amendment No. 13 to Reporting Person's statement on Schedule 13D. F3 · ownership.direct: Pursuant to the Amended and Restated Investor Agreement, dated as of January 11, 2014, by and among the Reporting Person, sanofi-aventis US LLC, Aventis, sanofi-aventis Amerique du Nord (collectively, the "Sanofi Parties") and the Issuer, the Sanofi Parties have agreed to vote their respective shares of the Issuer, subject to specified exceptions, in accordance with the recommendation of the Issuer's Board of Directors. Read SEC document |
| August 05, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 75,036 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · nonDerivative · entry 11 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 328,352 Read SEC document |
| August 05, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 75,036 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · nonDerivative · entry 6 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · by 2017 GRAT Disclosed balance after: 0 Read SEC document |
| July 02, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 16 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · by CLAT Disclosed balance after: 145,661 Read SEC document |
| June 13, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · nonDerivative · entry 10 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 253,316 Read SEC document |
| June 13, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · nonDerivative · entry 8 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · by 2019 GRAT Disclosed balance after: 500,000 Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:16 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 153,792 | $0.00 Strike: $21.25 | $0.00 |
DisclosureSEC source: 0001237899-19-000016 · edgardoc.xml · derivative · entry 8 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,793 Underlying: Common Stock · 153,792 shares Expires 2019-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:16 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Tax withholdingCommon Stock | 80,164 | $313.64 | $25,142,636.96 |
DisclosureSEC source: 0001237899-19-000016 · edgardoc.xml · nonDerivative · entry 2 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,505 Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:16 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Exercise / conversionCommon Stock | 153,792 | $21.25 | $3,268,080.00 |
DisclosureSEC source: 0001237899-19-000016 · edgardoc.xml · nonDerivative · entry 1 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2019 Filed Nov 12, 2019 21:05 UTC |
STAHL NEILEVP Research and Development
|
GiftCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-19-000010 · edgardoc.xml · nonDerivative · entry 1 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,150 Read SEC document |
| May 15, 2019 Filed May 16, 2019 00:42 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 1,000 | $305.93 | $305,930.00 |
DisclosureSEC source: 0001237899-19-000013 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,323 Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:02 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 3,278 | $306.37 | $1,004,280.86 |
DisclosureSEC source: 0001237899-19-000012 · edgardoc.xml · nonDerivative · entry 4 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,450 F2 · price: Represents volume-weighted average price of sales of 3,278 shares of Company stock on May 14, 2019 at prices ranging from $306.00 to $306.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2019 at each separate price. Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:02 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 6,575 | $305.43 | $2,008,202.25 |
DisclosureSEC source: 0001237899-19-000012 · edgardoc.xml · nonDerivative · entry 3 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,728 F1 · price: Represents volume-weighted average price of sales of 6,575 shares of Company stock on May 14, 2019 at prices ranging from $305.05 to $305.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2019 at each separate price. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:02 UTC |
STAHL NEILEVP Research and Development
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $52.03 | $0.00 |
DisclosureSEC source: 0001237899-19-000012 · edgardoc.xml · derivative · entry 7 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,079 Underlying: Common Stock · 25,000 shares Expires 2021-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: With respect to 75,000 underlying shares, the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 48,079 underlying shares, the stock option award vested in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:02 UTC |
STAHL NEILEVP Research and Development
|
Tax withholdingCommon Stock | 15,147 | $304.20 | $4,607,717.40 |
DisclosureSEC source: 0001237899-19-000012 · edgardoc.xml · nonDerivative · entry 2 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,303 Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:02 UTC |
STAHL NEILEVP Research and Development
|
Exercise / conversionCommon Stock | 25,000 | $52.03 | $1,300,750.00 |
DisclosureSEC source: 0001237899-19-000012 · edgardoc.xml · nonDerivative · entry 1 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2019 Filed Apr 18, 2019 23:04 UTC |
Fenimore Christopher R.VP Controller
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 350 | $0.00 Strike: $21.25 | $0.00 |
DisclosureSEC source: 0001237899-19-000011 · edgardoc.xml · derivative · entry 7 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 350 shares Expires 2019-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| April 18, 2019 Filed Apr 18, 2019 23:04 UTC |
Fenimore Christopher R.VP Controller
|
GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000011 · edgardoc.xml · nonDerivative · entry 3 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,897 F1 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust. Read SEC document |
| April 18, 2019 Filed Apr 18, 2019 23:04 UTC |
Fenimore Christopher R.VP Controller
|
GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000011 · edgardoc.xml · nonDerivative · entry 2 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,096 Read SEC document |
| April 18, 2019 Filed Apr 18, 2019 23:04 UTC |
Fenimore Christopher R.VP Controller
|
Exercise / conversionCommon Stock | 350 | $21.25 | $7,437.50 |
DisclosureSEC source: 0001237899-19-000011 · edgardoc.xml · nonDerivative · entry 1 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2019 Filed May 29, 2019 20:16 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 514 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000016 · edgardoc.xml · nonDerivative · entry 4 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · by CLAT Disclosed balance after: 146,330 Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 20:03 UTC |
SCHLEIFER LEONARD SDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 100 | $0.00 Strike: $21.25 | $0.00 |
DisclosureSEC source: 0001708138-19-000008 · edgardoc.xml · derivative · entry 3 SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,400 Underlying: Common Stock · 100 shares Expires 2019-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: With respect to 187,500 underlying shares, the option became exercisable on December 31, 2012, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2012. With respect to 125,000 underlying shares, the stock option award vested in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 20:03 UTC |
SCHLEIFER LEONARD SDirector · President & CEO
|
Exercise / conversionCommon Stock | 100 | $21.25 | $2,125.00 |
DisclosureSEC source: 0001708138-19-000008 · edgardoc.xml · nonDerivative · entry 1 SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 13, 2019 00:19 UTC |
Sanofi10% owner
|
SaleCommon Stock | 131,115 | $412.17 | $54,041,315.54 |
DisclosureSEC source: 0001140361-19-004808 · form4.xml · nonDerivative · entry 1 Sanofi · CIK 0001121404 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,723,717 F1 · kind: Private sale to the Issuer pursuant to the letter agreement entered into with the Issuer on January 7, 2018 and filed on January 9, 2018 by the Reporting Person as Exhibit 99.4 to Amendment No. 13 to Reporting Person's statement on Schedule 13D. F3 · ownership.direct: Pursuant to the Amended and Restated Investor Agreement, dated as of January 11, 2014, by and among the Reporting Person, sanofi-aventis US LLC, Aventis, sanofi-aventis Amerique du Nord (collectively, the "Sanofi Parties") and the Issuer, the Sanofi Parties have agreed to vote their respective shares of the Issuer, subject to specified exceptions, in accordance with the recommendation of the Issuer's Board of Directors. Read SEC document |
| February 19, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 150,722 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · nonDerivative · entry 9 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 753,316 Read SEC document |
| February 19, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 150,722 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · nonDerivative · entry 7 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · by 2018 GRAT Disclosed balance after: 249,278 Read SEC document |
| January 18, 2019 Filed Jan 18, 2019 22:01 UTC |
Fenimore Christopher R.VP Controller
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 150 | $0.00 Strike: $21.25 | $0.00 |
DisclosureSEC source: 0001237899-19-000008 · edgardoc.xml · derivative · entry 7 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350 Underlying: Common Stock · 150 shares Expires 2019-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| January 18, 2019 Filed Jan 18, 2019 22:01 UTC |
Fenimore Christopher R.VP Controller
|
GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000008 · edgardoc.xml · nonDerivative · entry 3 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,547 F1 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust. Read SEC document |
| January 18, 2019 Filed Jan 18, 2019 22:01 UTC |
Fenimore Christopher R.VP Controller
|
GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000008 · edgardoc.xml · nonDerivative · entry 2 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,096 Read SEC document |
| January 18, 2019 Filed Jan 18, 2019 22:01 UTC |
Fenimore Christopher R.VP Controller
|
Exercise / conversionCommon Stock | 150 | $21.25 | $3,187.50 |
DisclosureSEC source: 0001237899-19-000008 · edgardoc.xml · nonDerivative · entry 1 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 21:06 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,791 | $0.00 Strike: $273.67 | $0.00 |
DisclosureSEC source: 0001237899-19-000007 · edgardoc.xml · derivative · entry 3 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,791 shares Expires 2024-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 21:06 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 1,791 | $410.00 | $734,310.00 |
DisclosureSEC source: 0001237899-19-000007 · edgardoc.xml · nonDerivative · entry 2 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,323 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 21:06 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionCommon Stock | 1,791 | $273.67 | $490,142.97 |
DisclosureSEC source: 0001237899-19-000007 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| January 03, 2019 Filed May 29, 2019 20:16 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 569 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000016 · edgardoc.xml · nonDerivative · entry 3 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · by CLAT Disclosed balance after: 146,844 Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:05 UTC |
Zoghbi Huda YDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,784 | $0.00 Strike: $371.40 | $0.00 |
DisclosureSEC source: 0001708138-19-000006 · edgardoc.xml · derivative · entry 2 Zoghbi Huda Y · CIK 0001681643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,784 Underlying: Common Stock · 3,784 shares Expires 2029-01-02 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.